Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?

Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?
复制标题

DOI:
10.1111/j.1365-277x.2011.01215.x
复制
发表时间:
2012-04-01
影响因子:
3.3
通讯作者:
McKiernan, P.
McKiernan, P.
中科院分区:
医学3区
文献类型:
--
作者:
Daly, A.;Gokmen-Ozel, H.;McKiernan, P.

文献摘要

被引文献

相似文献

背景:1型酪氨酸血症(HT1)的治疗采用酪氨酸和苯丙氨酸限制饮食、不含苯丙氨酸和酪氨酸的氨基酸和硝西酮(NTBC)。治疗指南建议血浆酪氨酸在200-400 μ m之间,苯丙氨酸至少在100 - 30 μ m之间。关于HT1患者血浆酪氨酸或苯丙氨酸的日变化信息很少。低血浆苯丙氨酸
Background: Tyrosinaemia type 1 (HT1) is treated with a tyrosine and phenylalanine-restricted diet, amino acids free of phenylalanine and tyrosine, and nitisinone (NTBC). Treatment guidelines recommend plasma tyrosine between 200-400 mu m and phenylalanine at least >30 mu m. There is little information on the diurnal variation of plasma tyrosine or phenylalanine in HT1. Low plasma phenylalanine